CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Ziopharm Oncology, Inc. Company Snapshot
Ziopharm Oncology, Inc. operates within the Specialty outpatient clinics sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ziopharm Oncology with three other health care providers in North America: Creative Medical Technology Holdings Inc (2018 sales of $124,400.00 ), Spine Injury Solutions Inc ($1.84 million ), and Canfield Medical Supply Inc ($1.31 million ).

Sales Analysis. Sales fell dramatically in 2018: During the year ended December of 2018, sales at Ziopharm Oncology were $146,000.00 . This is a sharp decrease of 97.7% versus 2017, when the company's sales were $6.39 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Ziopharm Oncology, Inc.
  Stock Performance Chart for Ziopharm Oncology, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 4.46
(Figures in U.S. Dollars)
1 Week 0.3%   13 Weeks 12.9%  
4 Weeks -12.0%   52 Weeks 39.2%  
 
Ziopharm Oncology, Inc. Key Data:
  Ticker: ZIOP Country: United States
  Exchanges: NAS Major Industry: Health Care Equipment & Services
    Sub Industry: Specialty Outpatient Clinics
  2018 Sales 146,000
(Year Ending Jan 2019).
Employees: 48
  Currency: U.S. Dollars Market Cap: 806,488,739
  Fiscal Yr Ends: December Shares Outstanding: 181,030,020
  Share Type: Common Closely Held Shares: 3,458,547
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.